Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | AHR | P35869 | 1/20 | 0.47 |
| ▸ | KIF11 | P52732 | 11/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | GPR3 | P46089 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | CDK4 | P11802 | 1/20 | 0.36 |
| ▸ | CCND1 | P24385 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9983414 | 1.00 | KDM4E (0.52) | KDM4EATML3MBTL1AHRKIF11 | |
| SCHEMBL16397572 | 0.96 | AHR (0.53) | KDM4EATML3MBTL1AHRKIF11 | |
| SCHEMBL30353949 | 0.96 | AHR (0.53) | KDM4EATML3MBTL1AHRKIF11 | |
| SCHEMBL22514639 | 0.93 | AHR (0.50) | KDM4EATML3MBTL1AHRKIF11 | |
| SCHEMBL16397780 | 0.93 | AHR (0.50) | KDM4EATML3MBTL1AHRKIF11 | |
| SCHEMBL25006255 | 0.90 | KDM4E (0.43) | KDM4EATML3MBTL1AHRKIF11 | |
| SCHEMBL22514632 | 0.90 | KIF11 (0.62) | KDM4EATML3MBTL1AHRKIF11 | |
| SCHEMBL19937077 | 0.89 | KDM4E (0.48) | KDM4EATML3MBTL1AHRKIF11 | |
| SCHEMBL25963763 | 0.89 | KDM4E (0.46) | KDM4EATML3MBTL1AHRKIF11 | |
| SCHEMBL25006958 | 0.87 | AHR (0.44) | KDM4EATML3MBTL1AHRKIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11849634-B2 | Composition of matter for use in organic light- emitting diodes | KYULUX, INC. (JP) | 2023-12-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11849634-B2 | Composition of matter for use in organic light- emitting diodes | NDUFV3, NDUFV2, CRY2 | KDM4E 4409/4885ATM 2778/4885L3MBTL1 1938/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.